Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Paracrine signaling for tissue repair refers to a cell-cell communication process in which one cell type releases soluble molecules—such as growth factors, cytokines, and chemokines—that diffuse locally and influence neighboring cells. This mechanism is especially important in regenerative medicine and stem cell therapy. Rather than directly replacing damaged tissue with donor cells, transplanted stem cells often exert their therapeutic effects by secreting these paracrine factors. These secreted molecules stimulate endogenous patient cells to proliferate, reduce inflammation, promote angiogenesis (formation of new blood vessels), inhibit apoptosis (cell death), and enhance overall tissue regeneration. The beneficial effects can occur even if donor cells do not persist long-term within the recipient's tissues. Multiple cell types—including mesenchymal stromal/stem cells from bone marrow, adipose tissue, umbilical cord blood/tissue—can mediate these effects through their secretome composed of proteins and extracellular vesicles. The specific composition and efficacy of the secretome can vary depending on the source and preconditioning of the donor cells. Importantly, "paracrine signaling" itself is not a single molecular target but rather an umbrella term describing this mode of intercellular communication; it encompasses many different molecules acting through various receptors on target tissues[1][2][3][4]. Therefore it should not be considered a canonical therapeutic target like an individual receptor or enzyme. If you are seeking structured information about specific molecular targets within this process—such as particular growth factor receptors or cytokine pathways—it would be necessary to specify those individual components rather than "paracrine signaling" as a whole.
null (Paracrine signaling is a process, not a druggable target; drugs may modulate components such as growth factors or cytokines involved in paracrine pathways.)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Paracrine signaling (for tissue repair).